RRx-001, a novel epigenetic modulator: Resensitization to previously failed therapy in the ongoing phase 2 colorectal cancer study, ROCKET Reid, T., Fisher, G., Carter, C., Cho-Phan, C., Kunz, P., Oronsky, B., Fanger, G., Stirn, M., Caroen, S., Parker, C., Scicinski, J. AMER ASSOC CANCER RESEARCH. 2016

View details for DOI 10.1158/1538-7445.CHROMEPI15-B26

View details for Web of Science ID 000368930800036